Struggles with FDA continue for Lupin as it is handed another Form 483
Troubled generics manufacturer Lupin has struggled with FDA cleaning and process validation guidelines for the past four years. Now, the Indian company’s been hit with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
